🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: To describe the safety profile of a second dose of ProQu...
Status
Completed
Location
Multiple Locations
Start Date
2007-10-24
Trial ID
NCT00560755
Treatments Being Tested
The purpose of this study is to assess the immunogenicity and safety of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-02-06
Trial ID
NCT01506193
Treatments Being Tested
The purpose of this observer blinded study is to provide information on vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-20
Trial ID
NCT00578175
Treatments Being Tested
A prospective, multisite study to evaluate the Impact of Measles, Mumps, Ru...
Status
Completed
Location
Medical University of South Carolina, Pediatric Nephrology
Start Date
2015-12
Trial ID
NCT02687763
Treatments Being Tested
The primary study objectives are: * To demonstrate that a 2-dose regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-29
Trial ID
NCT00566527
Treatments Being Tested
This clinical trial will evaluate the safety of two injections of Menactra®...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00483574
Healthy children who received two doses of GlaxoSmithKline (GSK) Biological...
Status
Unknown
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT02712203
Treatments Being Tested
The purpose of this study is to assess non-inferiority of two different vac...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-09
Trial ID
NCT00969436
Treatments Being Tested
This is a modified single-blind, randomized, parallel-group, comparative, m...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00422292
Follow-up to evaluate the immunogenicity and safety of three production lot...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-07
Trial ID
NCT00406211
Treatments Being Tested